Targeting the Angiotensin II Type 1 Receptor in Cerebrovascular Diseases: Biased Signaling Raises New Hopes

Céline Delaitre, Michel Boisbrun, Sandra Lecat, François Dupuis

Open source

DOI
10.3390/ijms22136738
Published
2021-06-23
Container
International Journal of Molecular Sciences
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ijms22136738,
  title = {Targeting the Angiotensin II Type 1 Receptor in Cerebrovascular Diseases: Biased Signaling Raises New Hopes},
  author = {Céline Delaitre and Michel Boisbrun and Sandra Lecat and François Dupuis},
  year = {2021},
  journal = {International Journal of Molecular Sciences},
  doi = {10.3390/ijms22136738},
  url = {https://doi.org/10.3390/ijms22136738}
}

RIS

TY  - JOUR
TI  - Targeting the Angiotensin II Type 1 Receptor in Cerebrovascular Diseases: Biased Signaling Raises New Hopes
AU  - Céline Delaitre
AU  - Michel Boisbrun
AU  - Sandra Lecat
AU  - François Dupuis
PY  - 2021
JO  - International Journal of Molecular Sciences
DO  - 10.3390/ijms22136738
UR  - https://doi.org/10.3390/ijms22136738
ER  - 

APA

Delaitre, C., Boisbrun, M., Lecat, S., & Dupuis, F. (2021). Targeting the Angiotensin II Type 1 Receptor in Cerebrovascular Diseases: Biased Signaling Raises New Hopes. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms22136738

Source records